EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023 finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
EQS-News: Heidelberg Pharma AG / Key word: 9 Month figures
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023
12.10.2023 /.
EQS-News: Heidelberg Pharma AG / Key word(s): 9 Month figuresHeidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023 12.10.2023 / 07:09 CET/CESTThe issuer is solely responsible for the content of this announcement.Heidelberg Pharma AG: Interim Management Statement on the First Nine Months.
EQS-News: Heidelberg Pharma AG: Heidelberg Pharmas Partner Takeda Reached Development Milestone finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.
Investegate announcements from Heidelberg Pharma AG, Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate